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Abstract 
The importance of anxiety in the health of women and their children means the issue 
of how to measure anxiety during pregnancy and after birth is critical. Anxiety has 
been conceptualised in different ways in perinatal research, including pregnancy-
specific anxiety, anxiety symptoms, as well as the full range of anxiety disorders.  In 
this chapter we look at why it is important to identify perinatal anxiety and whether 
diagnostic criteria are relevant to women during this time. We then consider general 
issues and provisos we need to be aware of when measuring and screening for 
perinatal anxiety. In the final section we briefly outline different measures of anxiety 
disorders, symptoms, and pregnancy-specific anxiety. However, choice of measure is 
highly dependent on the purpose and context in which it is to be used. More research 
is needed to validate measures for use with perinatal women and provide normative 
data. Measurement of anxiety in men during this time is also important and needs 
addressing. 
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The importance of anxiety in the health of women and their children means the issue 
of how we measure anxiety during pregnancy and after birth is critical, although not 
without controversy. Anxiety is broadly defined as “an emotion characterized by 
feelings of tension, worried thoughts and physical changes like increased blood 
pressure” (American Psychiatric Association 2013). Symptoms include affective, 
cognitive and behavioural components. Diagnostic categories for anxiety disorders are 
varied and encompass generalised anxiety disorder, phobias, panic disorder, 
agoraphobia, social anxiety disorder, separation anxiety disorder, selective mutism, 
and  post-traumatic stress disorder before its reclassification as a trauma and stressor 
related disorder (DSM-5; American Psychiatric Association 2013). Different ways of 
conceptualising anxiety are reflected in perinatal research which has examined 
worries about pregnancy through to state symptoms through to diagnostic disorders.  
In this chapter we first look at why it is important to identify perinatal anxiety and 
whether diagnostic criteria are relevant to women during this time as well as general 
issues and provisos when screening for perinatal anxiety. The final section briefly 
outlines some questionnaire measures of anxiety symptoms and pregnancy-specific 
anxiety. 
 
Why is it important to identify perinatal anxiety? 
There is increasing evidence that anxiety disorders and sub-threshold symptoms 
negatively affect not only women’s well-being but also the child’s development. In 
addition, anxiety disorders before and during pregnancy predict postnatal anxiety and 
depression (Sutter-Dallay et al. 2004; Matthey et al. 2003; Mauri et al. 2010; Milgrom 
et al. 2008).  For example, anxiety in late pregnancy is associated with a more than 
three-fold risk of depression six to eight weeks postpartum (Austin et al. 2007; 
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Milgrom et al. 2008).  The relationship of antenatal anxiety with postnatal 
psychological disorders highlights the potential for antenatal screening to identify 
women who will continue to experience postnatal emotional difficulties. Even women 
who have symptoms of anxiety in pregnancy but do not fulfil diagnostic criteria are 
likely to report greater postnatal depressive symptoms (Skouteris et al. 2009). 
Screening for high levels of anxiety in pregnant or postpartum women is therefore 
important in its own right and enables targeted interventions to help reduce women’s 
distress. 
Furthermore, anxiety in pregnancy is associated with poor outcomes for 
infants and children (see Chapter 1). Poor birth and infant outcomes, such as 
complications in labor, low birthweight, low apgar scores, and detrimental changes in 
fetal heart rate and motor activity are associated with anxiety in pregnancy (Teixeira 
et al. 1999; Field et al. 2010; Berle et al. 2005; DiPietro 2010; Johnson and Slade 
2003). After birth, studies suggest prenatal anxiety predicts child behaviour problems 
from infancy through to teenage years, including attention problems, conduct disorder 
and emotional problems aged 4-6 (O’Connor et al. 2002; 2003); ADHD and 
externalizing behaviour problems aged 8-9 (Van den Bergh and Marcoen 2004); high 
impulsivity and low scores on cognitive tests aged 14-15 (Van den Bergh et al. 2005). 
Similarly, anxiety after birth is associated with emotional and conduct problems and 
increased somatic symptoms in children (Glasheen, Richardson and Fabio 2010). 
Helping women who have high levels of anxiety during their pregnancy is therefore 
important for both women and their developing infant. 
Much of the research on the impact of anxiety relies on self-report measures of 
anxiety symptoms as opposed to structured clinical interviews assessing anxiety 
disorders. This suggests that high anxiety symptoms are clinically significant in terms 
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of the impact on women and their children (Glasheen, Richardson and Fabio 2010; 
Rucci et al. 2003). It is likely that the effects of anxiety disorders may be even more 
severe. However, information on the prevalence and course of anxiety over the 
perinatal period is mixed.  
 
Prevalence 
Use of different time points and measures of perinatal anxiety mean it is hard 
to draw an overall picture of the prevalence of perinatal anxiety. Large 
epidemiological studies of postnatal anxiety report varying prevalence rates and 
patterns of anxiety prevalence between pregnancy and postpartum. For example, a 
large epidemiological study of over 8,000 women in the UK reported that women’s 
symptoms of anxiety were stable throughout pregnancy with a small drop after birth 
(Heron et al. 2004). In contrast, a large cohort longitudinal study of maternal mental 
health in Australia found an increase in anxiety after birth with 7.3% of women 
experiencing intense anxiety or panic attacks occasionally or often during pregnancy, 
increasing to 15.7% in the first three months postpartum (Woolhouse et al. 2009).   
In terms of anxiety disorders, research using structured clinical interviews 
suggests generalized anxiety disorder (GAD) is most common and experienced by 
between 1.9 and 8.2% of women six to eight weeks postpartum (Ballard et al. 1993; 
Matthey et al. 2003; Wenzel et al. 2005).  A study of women referred for perinatal 
psychiatric treatment found that the most common primary diagnosis was GAD 
followed by major depressive episode, with a high level of comorbidity (Grigoriadis 
et al. 2011). Prevalence of both GAD and obsessive compulsive disorder is higher in 
perinatal samples than the general population (Ross and McLean 2006). The 
prevalence of panic disorder (1.4%, Wenzel et al. 2005) and posttraumatic stress 
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disorder (1.7 - 9%, Beck et al., 2011) is comparable to the general population (Ross 
and McLean 2006).  
In addition a substantial proportion of women experience high levels of 
anxiety but do not fulfil all diagnostic criteria. For example, in a study where 8.2% of 
postpartum women had GAD a further 19.7% of women were classified as having 
subsyndromal GAD (Wenzel et al. 2005).  This is consistent with evidence from the 
general population in primary care that equal if not higher numbers of people 
experience subsyndromal anxiety (Olfson et al. 1996; Rucci et al. 2003) with similar 
levels of distress, disability and poor subjective health as those who have the full 
disorder (Rucci et al. 2003). 
 
Relevance of standard diagnostic criteria to perinatal women 
Given the prevalence of sub-threshold anxiety symptoms in the perinatal population, 
using diagnostic criteria for women in the perinatal period has been questioned 
(Matthey and Ross-Hamid 2011, Martini et al. 2010).  Diagnostic criteria have been 
considered by some to be artificial constructs which not everyone with clinically 
significant anxiety will conform to (Matthey and Ross-Hamid, 2011; van Praag 1998; 
Liebowitz 1993). In addition, diagnostic criteria may not account for perinatal-
specific problems. For example, Phillips et al. (2009) found that just as many women 
in their sample were diagnosed with ‘anxiety disorder not otherwise specified’ as 
those with Generalised Anxiety Disorder.  Whilst ‘anxiety disorder not otherwise 
specified’ is still a disorder, this highlights how anxiety disorders might not be well-
specified for postnatal women. Most women in this category experienced 
uncontrollable worry about motherhood or their infant.  
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Thus there may be perinatal-specific problems which are not covered by 
standard psychiatric classifications, such as a maternally focussed worry disorder 
(Phillips et al. 2009), severe fear of childbirth (tocophobia : Hofberg & Brockington 
2000) or bonding disorders (Klier 2006).  Focusing on specific perinatal problems 
may enable better prediction of outcomes and more appropriate targeting of primary 
and secondary interventions.  For example, pregnancy-specific anxiety has been 
shown to be a better predictor of poor birth and developmental outcomes than general 
anxiety (Buss et al. 2010; DiPietro et al. 2002; Huizink et al. 2003; Roesch et al. 
2004; Wadhwa et al. 1993). 
A final concern that has been raised is that perinatal symptoms and issues 
common among new mothers, such as sleep deprivation, can inflate diagnostic 
symptoms and be misinterpreted as pathological. For example, symptoms of GAD 
include feeling tired and having difficulty sleeping which is common for women 
looking after a new baby. Similarly, somatic symptoms in pregnancy can overlap with 
anxiety symptoms such as palpitations, numbness, and sweaty hands. Rates of anxiety 
disorders, particularly GAD, may therefore be over-estimated if using diagnostic 
criteria (Matthey and Ross-Hamid 2011). Conversely, such symptoms may be 
discounted as part of the common experience of being pregnant, resulting in under-
diagnosis. Skilled clinicians therefore need to try to disentangle symptoms of mental 
health problems from non-pathological aspects of pregnancy and the postpartum. 
The relevance, or not, of standard diagnostic criteria to perinatal anxiety raises 
important issues about using diagnostic criteria as the gold standard against which to 
determine cut-off scores or criteria for probable anxiety. Therefore it may be useful to 
develop and use other approaches in combination with standard diagnostic criteria. 
One alternative is to use normative data for self-report anxiety measures to identify 
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the top percentile of women with extreme anxiety.  Which percentile is used needs 
further examination and could be based on different criteria such as expected 
prevalence of clinically significant anxiety or women’s need for treatment. For 
example, if we expect 15% of women to have clinically significant anxiety we would 
use the 85% percentile to determine the appropriate cut-offs. In order to use this 
approach normative data need to be available on each measure for pregnancy. 
These issues raise questions over whether provision of treatment should be 
based only on diagnostic criteria and a full psychosocial assessment is recommended 
(see Chapter X). 
 
Issues to consider when measuring perinatal anxiety 
The issue of measurement validity and lack of a gold standard is only one of a number 
of issues to consider when measuring anxiety during pregnancy and after birth. Other 
critical issues include the purpose of measurement, timing of measure, whether we are 
measuring transient or enduring anxiety, and the conceptual overlap between anxiety 
and general measures of distress. These issues are considered in turn below. 
 
Purpose of measurement 
The first issue to consider when contemplating measuring perinatal anxiety is the 
purpose of the measurement and the context in which it is being done.  In a clinical 
context the purpose of measurement is usually to identify women who require help or 
treatment. The focus at this stage is usually on detecting whether a woman is having 
difficulties with anxiety or psychological problems for which she would like help. 
Further detailed assessment can then ascertain the more precise nature of her 
difficulties and work out which referral or treatment is most appropriate. Diagnosis 
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does not necessarily need to be a part of this process but, if it is, would usually occur 
after initial assessment. 
 In a research context,  anxiety is commonly measured to examine the 
relationship between symptoms of anxiety and other outcomes, or to report rates of 
women scoring ‘high’, or who are ‘probably anxious’. Use of different measures and 
cut-off scores means rates of anxiety reported in different studies are often not 
comparable.  
 
Transient versus enduring anxiety 
Whether screening is used in clinical or research contexts, current evidence suggests 
that anxiety should be measured at least twice over a period of a few weeks to 
distinguish between transient and enduring distress (Ballestrem et al. 2005; Matthey 
and Ross-Hamid 2012; Wickberg and Hwang 1996). . Diagnosing women on the basis 
of a state measure of anxiety taken at one time point could result in many women 
being identified as anxious when this is not the case (i.e. false positives) as it is 
common to have a few anxious days which are not representative of general mood. 
Empirical studies have shown that such transient mood difficulties are common in the 
perinatal period. For example, studies of postnatal depression indicate that more than 
half of women who score as having ‘probable depression’ on the EPDS do not have 
ongoing mood difficulties (Ballestrem et al. 2005; Wickberg and Hwang 1996). There 
is evidence this is also true for anxiety in pregnancy, with Matthey and Ross-Hamid 
(2012) showing that around 50% of women scoring ‘high’ on anxiety (or depression) 
measures are no longer highly anxious (or depressed) two weeks later. 
Thus whether screening for anxiety or depression the distinction should 
always be made between transient and enduring symptoms. In the clinical context, 
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questions such as “why do you think you’re feeling this way?” and “how do you think 
you may be feeling in 2 weeks or so?” can be asked in the context of a broader 
psychosocial assessment (see Chapter 9 of this book).  Ignoring these questions and 
referring all ‘high scorers’ to specialist health services, or reporting rates of women 
with ‘high anxiety’ based upon single administration of an anxiety scale, may 
pathologise transient symptoms. A consequence of this is that healthcare resources 
may not be used efficiently. 
 
Timing of screening 
Another difficult issue is when to screen for anxiety. Screening in pregnancy has the 
potential to identify women who are at risk of worse birth outcomes and postpartum 
psychological problems. This in turn would enable early intervention in pregnancy. 
However, the issue of transient anxiety is particularly pertinent. There is some 
consensus that during pregnancy anxiety is higher in the first and third trimesters (eg. 
Da Costa et al. 1999; Fertl et al. 2009; Figueiredo and Conde 2011). In the second 
trimester anxiety may be lower because normal stressors are likely to have dissipated, 
such as morning sickness, initial concern over the baby’s development, and adjusting 
to the realisation of being pregnant. In the third trimester, anxiety might increase as a 
result of increasing physical limitations and the prospect of labor and birth. However, 
there is substantial variation across women (Heron et al. 2004). For example, a 
woman who has had a previous late-miscarriage or stillbirth is likely to continue to be 
highly anxious throughout pregnancy.   
Screening for postnatal anxiety and depression in the UK has traditionally 
been done at 10-14 days,  six to eight weeks postpartum which coincides with visits 
from healthcare professionals and health reviews for the new baby (Department of 
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Health, 2009).. On the one hand, this is a time when women may have recovered 
physically from the birth and got used to coping with the new baby so ratings may be 
a better indication of enduring anxiety. On the other hand this may be a time when 
support from family, partners and healthcare professionals is reduced and women may 
become anxious about being the sole carer of the child for much of the time. As with 
pregnancy, there is also considerable variability across women with respect to when 
and why they may feel highly anxious after birth suggesting a need for further 
research.  
It is therefore likely that given current evidence there is no ‘absolutely best’ 
time to screen for anxiety in pregnancy or after birth. Rather, we need to be mindful 
of normal, potentially transient changes in anxiety. The following factors can be used 
as a guide for when to screen for anxiety: (i) from a pragmatic perspective it is easier 
to screen at a time when most women are in contact with health services; (ii) 
screening early in pregnancy is preferable if the aim is to intervene to reduce levels of 
anxiety; (iii) repeat testing is advisable of women scoring in the ‘highly anxious or 
distressed’ range. This latter point can be facilitated by brief screening tools of one or 
two questions that can be used at antenatal and postnatal visits. This is examined in 
the next section.   
 
Diagnostic interviews to assess anxiety 
The current ‘gold standard’ of measuring mental health problems in the perinatal 
period is to use clinical diagnostic interviews based on DSM or ICD criteria for the 
relevant disorder. Diagnosis takes place via use of a diagnostic interview with a 
practitioner trained in using the interview. Diagnostic interviews can be semi- or 
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highly-structured. This section briefly outlines some of the diagnostic interviews 
commonly used in perinatal research and practice. 
 
Structured Clinical Interview for DSM-IV diagnosis (SCID-I) 
The SCID-I (First et al. 2002) is a semi-structured interview for current and lifetime 
history of DSM-IV disorders. Screening questions relating to current and lifetime 
experience of the individual anxiety disorders are asked and women responding 
positively can then be interviewed using the relevant section(s) of the anxiety 
disorders module. In some studies GAD duration criteria have been altered to identify 
generalized anxiety since childbirth (rather than the 6 months duration criterion 
usually used; Matthey et al 2003, Wenzel et al. 2005).  
 
Mini International Neuropsychiatric Interview (MINI) 
The MINI (Sheehan et al. 1998) was designed to be compatible with international 
diagnostic criteria to diagnose common mental health disorders and to be 
considerably shorter (approximately 15 minutes administration time) than other 
diagnostic interviews. It has shown reliability and established validity when compared 
to the SCID and expert professional opinion (Sheehan et al. 1998). It can be 
administered by lay interviewers who have undergone training as well as trained 
mental health professionals. The MINI can detect lifetime and current mania and 
panic disorder and current agoraphobia, social phobia, specific phobia, obsessive-
compulsive disorder, generalized anxiety disorder and posttraumatic stress disorder. 
“Current” is defined as “in the past month” for all diagnoses except generalized 
anxiety disorder, which has a six-month time frame. 
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The Composite International Diagnostic Interview (CIDI) 
Robins et al (1988) devised the CIDI primarily for use in epidemiological studies 
across different cultures and settings but it is widely used in clinics and for research. 
Symptom questions, clinical probe questions and time-related questions of first and 
last occurrence of a syndrome or diagnosis are highly standardized resulting in a high 
level of consistency of symptom assessment and reliability of diagnostic decisions 
(Wittchen, 1993). The CIDI has highly detailed instructions allowing non-clinicians to 
use it reliably after a period of comprehensive training in a World Health 
Organization designated centre (Wittchen, 1993). Symptom questions assess mental 
disorders according to definitions and criteria of both the DSM and the ICD. Modules 
assessing anxiety disorders (panic, agoraphobia, social phobia, simple phobia and 
generalized anxiety disorder) and posttraumatic stress disorder are available. The 
CIDI has shown reliable in terms of consistency between two interviewers and is 
time-efficient (Wittchen, 1993). 
 
Questionnaire Measures of Anxiety 
There are many questionnaire measures of anxiety – both for general anxiety 
symptoms and for pregnancy or postpartum-related anxiety. In this section we outline 
a few of the most commonly used measures with information on reliability and 
validity. More detailed reviews can be found elsewhere (Meades and Ayers 2011). 
New questionnaire measures of mental health are also being developed and evaluated 
in other populations (e.g. the Kessler 10 (Kessler et al., 2002) and CORE 10 
(Barkham et al., 2013)). These are promising but not included here because they have 
not yet been widely used or evaluated with perinatal women. 
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State-Trait Anxiety Inventory (STAI) 
The STAI (Spielberger, Gorsuch and Lushene 1970) shows acceptable reliability and 
has been widely validated. It is one of the most commonly used measures of anxiety 
symptoms (Glasheen et al. 2010). It comprises two scales each with 20 items: a state 
anxiety scale and a trait anxiety scale. The state scale’s instructions are for the person 
to complete the measure indicating how he/she feels “right now, that is, at this 
moment” (original italics). Unfortunately this state measure has been used frequently 
in perinatal studies where the exact ‘moment’ being measured has not been 
standardised or controlled, thus making any findings questionable. For example, 
Aktan (2012) reports having participants complete the STAI-S at home, and Paul et al 
(2013) administered the measure to participants over the phone. In both cases it is not 
possible to know what was happening for the women at the moment when they 
completed the scale – some may have been stressed if, for example, they had just had 
an argument; while others may have been more relaxed due to circumstances at that 
time.  
        In addition, items such as ‘I feel comfortable’ and ‘I am relaxed’ may be affected 
by the normal sequelae of the physical changes during pregnancy, such as becoming 
larger (and thus feeling uncomfortable, and not relaxed). Given the requirement for 
women to complete the items for how she is feeling “right now”, it is likely that for 
some women this will detect transient anxiety, much of which could be normal (eg., 
concern over the health of the baby), and not just enduring anxiety. The State version 
should therefore only be used when assessing anxiety in a specific situation (e.g. just 
before an ultrasound scan) that can be standardised across all the participants. And 
consideration should be given to items that could be affected by normal physical 
changes of pregnancy (or the postpartum). 
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  The trait subscale measures a more general or enduring individual tendency to react 
with heightened anxiety. Symptoms are endorsed on a four-point scale (1-4), thus the 
maximum score on one scale is 80. Examples of items are ‘I am a steady person’ and 
‘I lack self-confidence’. Both scales correlate highly with measures of depression 
(Stuart et al. 1998). A shorter 6 item scale has been developed and validated for use in 
pregnant women with correlations of greater than 0.90 between the original and 
shorter version scores (Marteau and Bekker 1992). 
In perinatal samples the cut-off scores used for the 20-item trait scale vary. For 
example, Barnett and Parker (1985) used 32 or more for ‘moderate’ anxiety and 45 or 
more for ‘high’ anxiety in women 3 weeks postpartum. However, Grant et al (2008) 
found that scoring 41 or more gave the best sensitivity, specificity and positive and 
negative predictive values to identify cases of anxiety in late pregnancy and was 
associated with a six-fold increase in postnatal anxiety disorders and depression. The 
trait scale also seems to be affected by anxious state in perinatal samples, as test-retest 
correlations range between 0.37 and 0.85 and lower scores are found after birth 
(Hundley et al. 1998). 
  
Hospital Anxiety and Depression Scale – anxiety subscale (HADS-A)  
The HADS (Zigmond and Snaith 1983) consists of two subscales of depression and 
anxiety, which each have seven items. Anxiety items are general e.g. ‘I get sudden 
feelings of panic’ and ‘Worrying thoughts go through my mind’. However, a few 
items may be confounded by symptoms of pregnancy e.g. ‘I can sit at ease and feel 
relaxed’, ‘I feel restless as if I have to be on the move’. Symptoms are endorsed on a 
four-point scale (0-3) over the last seven days, thus the maximum score is 21. Scores 
of 0-7 are considered ‘normal’, 8-10 suggestive of anxiety and 11 or more indicates 
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probable disorder (Snaith 2003). Validation of cut-offs suggests a lack of consistency. 
In a non-perinatal sample Bjelland et al. (2002) found a score of 8 or above gives 
optimal sensitivity and specificity. This has subsequently been used in three studies 
validating the HADS-A in pregnancy. However, this cut-off resulted in unusually 
high prevalence rates in UK (36-56%) and Uzbekistani (38-42%) samples (Jomeen 
and Martin 2004; Karimova and Martin 2003). A recent study found a cut-off score of 
9 or more identified the top 15% of English-speaking women on this measure in their 
sample (Matthey et al. 2013b). 
The HADS-A does not correlate highly with other measures of anxiety e.g. the 
EPDS-A (described below) indicating these measures pick up different facets of 
anxiety (Matthey et al. 2013b). The factor structure of the HADS is also unclear with 
between 2 and 5 factors being found including both depression and anxiety items 
(Bjelland et al. 2002; Jomeen and Martin, 2004; Karimova and Martin, 2003). 
However, internal reliability is usually good (Karimova and Martin, 2003). Studies 
validating the HADS-A in postpartum samples are scarce so further work is needed. 
 
Edinburgh Postnatal Depression Scale - anxiety subscale (EPDS-3A) 
Although not designed to detect anxiety, a review of research suggests three items on 
the EPDS (Cox et al. 1987) can be used to detect anxiety in perinatal women (Matthey 
et al. 2013a). The items are “I have blamed myself unnecessarily when things went 
wrong”, “I have been anxious or worried for no good reason” and “I have felt scared 
or panicky for no very good reason”. These load onto an anxiety subscale in factor 
analyses in ante- and postnatal populations and there is also some evidence to suggest 
that the subscale can distinguish anxious and depressive disorders (Matthey et al. 
2013a; Bowen et al. 2008; Ross et al. 2003). However, other studies suggest separate 
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subscale scores may not be accurate (Reichenheim et al. 2011) and that using the 
usual total scale cut-off (i.e. 13 or more) might not identify all women with anxiety 
disorders (Matthey, 2008;. Further research examining this is therefore needed. Scores 
range from 0–9 for the anxiety subscale and 0–30 for the total EPDS.  
 
Pregnancy-specific measures of anxiety 
Specific measures of anxiety during pregnancy are available, although there is 
sometimes conceptual overlap between these and measures of pregnancy-related 
worries, stress and distress, which often include anxiety-type affective items. For 
example, a review of pregnancy stress measures identified 15 questionnaires which 
broadly fell into either stressor measures, emotional response measures (e.g. anxiety), 
and multidimensional measures (Alderdice, Lynn and Lobel 2012). Three pregnancy-
specific anxiety measures are outlined briefly below. 
 
Pregnancy-Related Anxiety Questionnaire (PRAQ) 
The PRAQ (Van den Bergh 1989; Van den Burgh 1990) is the longest scale available 
with 55 items covering five subscales of fear of delivery (9 items), fear of bearing a 
handicapped child (6 items), concerns about partner relations (11 items), concerns 
about mood (11 items), and fear of change (8 items). Responses are rated on a Likert 
scale from 1 to 7 giving a possible range of 55 to 385. Internal reliability is good (van 
Bussel, Spitz and Demyttenaere 2009) but no other psychometric information are 
available. Shorter 34-item and 10-item versions have been developed using factor 
analysis (Gutteling et al 2006; Huizink et al. 2004; Huizink et al. 2002) with three 
subscales identified: fear of birth (e.g. ‘I am worried about the pain of contractions 
and the pain during delivery’), fear of bearing a handicapped child (e.g. ‘I am worried 
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that the baby will be abnormal’), and pregnancy-related concerns about one’s 
appearance (e.g. ‘I am worried about the fact that I shall not regain my figure after 
delivery’). The shorter versions of the PRAQ are associated with perceived stress, 
hassles, and alcohol use in pregnancy (Arch 2012; Gutteling et al. 2006; Huizink et al. 
2004; Huizink et al. 2002). 
 
Pregnancy Anxiety Scale (PAS) 
The PAS (Levin 1991) is a brief and retrospective questionnaire of 10 items that 
measure anxiety about being pregnant (3 items, e.g. ‘did you fear that you would fall 
and hurt your baby?’), giving birth (4 items, e.g. ‘were you afraid the pain of 
childbirth would be bad?’) or being in hospital (3 items, e.g. ‘were you afraid you 
would be alone the hospital?’). Responses are true/false giving a possible range of 0 
to 10. The scale was extracted from 25 items using confirmatory factor analysis 
(Levin 1991). Although the scale has been used in a few subsequent studies (e.g. 
Poikkeus et al 2006) very little other information on reliability and validity is 
available. There is also no information on cut-offs or the point at which anxiety 
becomes clinically meaningful.  
 
Pregnancy-Specific Anxiety Scale (PSAS) 
The PSAS (Roesch et al. 2004) is a very short 4-item questionnaire which was 
extracted from a larger pool of items using factor analysis. Items are similar to the 
STAI in that they ask how often women have felt anxious, concerned, afraid, and 
panicky in the last week, but in the context of pregnancy. Responses are scored from 
1 to 5, giving a possible range of 4 to 20. The PSAS has been used in various studies 
with inconsistent results. For example, it has been associated with shorter gestation 
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(Roesch et al. 2004) and preterm birth (Kramer et al. 2009) but this was not replicated 
in a sample of African American women (Dominguez et al. 2005). Internal reliability 
is also low in some instances (Roesch et al. 2004). 
 
Whether to measure anxiety or general distress 
One further that arises when measuring perinatal anxiety is whether it more 
appropriate to use a specific measure of anxiety or a measure of general distress. This 
is likely to vary according to the purpose and context in which screening is being 
done.  For research, a specific measure of anxiety with good criterion validity is 
essential if we are to understand the causes and consequences of perinatal anxiety 
further. However, in the clinical context it may be useful to use one or two general 
questions to get a quick screen for any perinatal distress, regardless of whether it is 
‘anxiety’, ‘stress’, or ‘depression’ as a guide for later follow-up. Such questions are 
currently available but further research is required to ascertain their sensitivity and 
specificity so that the clinician can have confidence in their use. Two examples are 
the Whooley questions for depression (Whooley 1997) which are used by UK health 
services to screen for depression in pregnancy and after birth; and the Matthey 
Generic Mood Questions in Box 1 which have been developed and piloted in 
Australia (MGMQ; Matthey et al. 2013b). 
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Box 1. The Matthey Generic Mood Question (MGMQ) (cf. Matthey et al. 2013b) 
Q.1a In the last 2 weeks have you felt very stressed, anxious or 
unhappy, or found it difficult to cope*, for some of the time? 
Yes (go to Q.1b) 
Possibly (go to Q.1b) 
No 
Q.1b How bothered have you been by these feelings? Not at all 
A little bit 
Moderately  (go to Q.1c) 
A lot  (go to Q.1c) 
Q.1c Is there anything in particular that is making you feel this way? 
 
Describe:  
 
 
*The author is investigating the inclusion of the word ‘manage’ to this question.  
 
Conclusion and recommendations 
In summary, anxiety symptoms are common in pregnancy and after birth and some 
disorders, such as GAD, are more prevalent than normal during this time. However, 
diagnostic criteria may be confounded by normal symptoms of pregnancy and 
postpartum and not recognise perinatal-specific problems, such as fear of birth or 
worries about the baby. There is also evidence that those who do not fulfil diagnostic 
criteria but have sub-syndromal symptoms may report similar levels of distress, 
disability and poor subjective health. 
Issues that need to be considered before screening for anxiety include 
considering what we are screening for, when the best time is to screen, and to ensure 
screening is not confounded by normal fluctuations in anxiety during pregnancy and 
after birth. In terms of screening tools, a range of general anxiety and pregnancy-
specific anxiety questionnaires are available, with varying reliability and validity. 
Questionnaires vary in the symptoms they focus on and therefore concordance 
between them can be poor.  There is also often conceptual overlap with measures of 
stress, distress and worry. Where cut-offs are available these are usually determined 
by comparison with diagnostic criteria. 
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On the basis of the evidence covered here we can make a number of 
recommendations. The first is that anxiety screening needs to be repeated to avoid 
over-pathologising transient distress.  Secondly, in clinical contexts it may be useful 
to use a 2-stage process where brief screening questions are used to identify women 
with any emotional distress who may benefit from more detailed assessment at a 
subsequent stage, although further research evaluating this approach is needed.  
Finally, there are a number of anxiety questionnaires available that have different 
strengths and weaknesses. Choice of measure will be highly dependent on the purpose 
and context in which it is to be used.  The STAI has been most validated and may 
useful in research as a specific measure of anxiety. The HADS-A has shown good 
reliability in pregnancy. New measures are also being developed which appear 
promising (eg. Kessler-10). However, more research is needed on the validity of 
different measures in perinatal women and to provide normative data for measures at 
different time points so appropriate cut-offs can be identified. Similarly, research 
needs to examine men’s anxiety during this time and consider respective 
measurement issues. 
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